Agilon Health, Inc.
HealthcareNYSE:AGL · New York Stock Exchange
-$3.25 today
Vol 0.26M · Avg 0.40M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
-319.8%
avg -45.6%
ROIC
-196.7%
avg -56.9%
ROA
-31.9%
avg -25.4%
Analysis
ROA is currently the strongest return metric at -31.9% versus its period average of -25.4%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Jeffrey Alan Schwaneke | Executive Vice President & Chief Financial Officer | $910,875.00 | — | 50 | $140,342.00 | 0.84% |
Benjamin Shaker | Chief Markets Officer | $657,545.00 | — | 43 | $122,850.00 | 0.74% |
Denise Zamore | Chief Legal Officer & Secretary | $623,408.00 | — | 51 | $66,112.00 | 0.40% |
Girish Venkatachaliah | Chief Technology Officer | $618,579.00 | — | 52 | $38,236.00 | 0.23% |
Kenny Bellendir | Markets Chief Financial Officer | — | — | — | — | — |
Evan Smith | Senior Vice President of Investor Relations | — | — | — | $4,126.00 | 0.02% |
Timothy Gertsch | Chief Accounting Officer | — | — | 39 | $14,169.00 | 0.08% |
Timothy Patrick O'Rourke | CEO & Director | — | — | — | $14,169.00 | 0.08% |
Heidi Hittner | Chief Business Operations Officer | — | — | — | — | — |
Leland Thomas | Senior Manager of Investor Relations | — | — | — | $24,014.41 | 0.14% |
Ronald Allan Williams | Executive Chairman | — | — | 77 | $149,141.00 | 0.89% |
Bill Farry | Chief of Technology Innovation | — | — | — | — | — |
Karthik Rao | Chief Medical Officer | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
2
$351,990.90
Sells
0
$0.00
Net Sentiment
+$351,990.90
Net buying
Most Active
Shaker Benjamin
1 transactions
| Date | Insider | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| Mar 2, 2026 | Shaker Benjamin Direct | Buy | 500.0K | $0.60 | $301,050.00 | |
| Nov 12, 2025 | Wulf John William Direct | Buy | 81.0K | $0.63 | $50,940.90 |
Analysis
Insiders reported 2 buys worth $351,990.90 and 0 sells worth $0.00 over the last 12 months. That adds up to net buying of $351,990.90. Shaker Benjamin was the most active insider with 1 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A5 analysts |
| Revenue | N/A | N/A | +52.4% | +10.4% (7yr)7 analysts |
| Net Income | N/A | N/A | N/A | N/A7 analysts |
| EBIT | N/A | N/A | N/A | N/A7 analysts |
Analysis
Recent growth has been strongest in Revenue at +52.4% over three years. Forward estimates point to Revenue at +10.4% (7yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Enhabit, Inc.
EHAB
$706.91M
Annexon, Inc.
NASDAQ:ANNX
$563.29M
Charming Medical Limited Class A Ordinary Shares
MCTA
$445.55M
DBV Technologies S.A.
NASDAQ:DBVT
$416.60M
SOPHiA GENETICS S.A.
NASDAQ:SOPH
$349.74M
Simulations Plus, Inc.
NASDAQ:SLP
$329.75M
Larimar Therapeutics, Inc.
NASDAQ:LRMR
$296.96M
Definitive Healthcare Corp.
NASDAQ:DH
$88.59M
enGene Holdings Inc.
NASDAQ:ENGN
$82.94M
Nakamoto Inc.
NASDAQ:NAKA
$75.18M
Who manages AGL?
Agilon Health, Inc. (AGL) lists 13 active executives. The top listed executive is Kenny Bellendir, Markets Chief Financial Officer.
Are AGL insiders buying or selling?
Recent insider activity shows net selling of $1.94B.
Explore More
Continue the stock analysis
Jump to another research area for this company.